A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.
Two cryo-EM studies pave the way for possible drugs to treat neurodegenerative disorder affecting millions. An elusive protein that many consider the key of fully understanding the causes of genetic Parkinson’s disease has come much more clearly into focus. Impacting millions around the world, Parkinson’s is a neurological disorder that…
Irvine, Calif. — UCI Health is pleased to announce the opening of its latest Newport Beach location, which is dedicated to preventing disease and managing health by considering all aspects of a patient’s mind, body and spirit. UCI Health — Newport Beach is the first to offer a comprehensive model…
UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.
Tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance
Irvine, Calif., Aug. 13, 2020 — The University of California, Irvine is bringing world-class healthcare services to coastal and southern Orange County with plans to build the UCI Health Center for Advanced Care, which will be home to the Center for Children’s Health, adult specialty care, urgent care and other…
Researchers at UC San Diego School of Medicine report successfully implanting specialized grafts of neural stem cells directly into spinal cord injuries in mice, then documenting how the grafts grew and filled the injury sites, mimicking the animals’ existing neuronal network.
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.
